Covid-19 vaccine trials for children begin | Full Report

The screening of children for trial of Covaxin, India's first indigenously developed COVID-19 vaccine, among those aged between 2 and 18 started at the AIIMS.

The trial on children has already started at AIIMS Patna to see if the Bharat Biotech jab is suitable for children.

Participants would be given the vaccine after their screening report comes.

The trial is to be conducted on 525 healthy volunteers. In the trial, the vaccine will be given by intramuscular route in two doses at day 0 and day 28.